DRUG EBITDA Growth
Bright Minds Biosciences Inc · EBITDA Growth
DRUG EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-283.96%period ending
DRUG TTM EBITDA YoY % (-29.99% → -283.96%)
Year-over-year change
High-resolution chart · PNG
DRUG ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -283.9591% | |
| -716.1614% | |
| -1,894.1305% | |
| -345.3637% | |
| -153.6735% | |
| 34.9754% | |
| 85.0891% | |
| 62.6199% | |
| 60.1582% | |
| 29.193% | |
| -26.1037% | |
| -147.0293% | |
| -378.7643% | |
| 100% | |
| 100% | |
| 100% | |
| -29.9937% |